litlas
Log inCreate account

Ira M. Jacobson

Active 1985–2025

Also published as
IRA M. JACOBSON
117
Papers
36,356
Citations
87
h-index
113
i10-index

Citations

Citations per year for Ira M. Jacobson1986: 4 citations1987: 6 citations1988: 3 citations1989: 3 citations1990: 9 citations1991: 37 citations1992: 35 citations1993: 53 citations1994: 49 citations1995: 43 citations1996: 31 citations1997: 45 citations1998: 45 citations1999: 33 citations2000: 32 citations2001: 35 citations2002: 28 citations2003: 28 citations2004: 31 citations2005: 46 citations2006: 75 citations2007: 94 citations2008: 117 citations2009: 111 citations2010: 154 citations2011: 221 citations2012: 311 citations2013: 358 citations2014: 557 citations2015: 563 citations2016: 412 citations2017: 278 citations2018: 248 citations2019: 684 citations2020: 578 citations2021: 492 citations2022: 356 citations2023: 260 citations2024: 427 citations2025: 204 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,254 citing papers, 26.4% of this breakdownChina: 542 citing papers, 6.4% of this breakdownUnited Kingdom: 492 citing papers, 5.8% of this breakdownFrance: 481 citing papers, 5.6% of this breakdownGermany: 474 citing papers, 5.6% of this breakdownItaly: 436 citing papers, 5.1% of this breakdownCanada: 332 citing papers, 3.9% of this breakdownJapan: 313 citing papers, 3.7% of this breakdownSpain: 266 citing papers, 3.1% of this breakdownAustralia: 244 citing papers, 2.9% of this breakdownTaiwan: 188 citing papers, 2.2% of this breakdownSwitzerland: 149 citing papers, 1.7% of this breakdown
0%26.4%Other 27.6%

Institutions

Fields

  • Medicine87.5%
  • Biochemistry, Genetics and Molecular Biology5%
  • Immunology and Microbiology3.3%
  • Neuroscience1.4%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Computer Science0.4%
  • Other1.9%

Topics

  • Hepatitis C virus research18.6%
  • Liver Disease Diagnosis and Treatment14.2%
  • Hepatitis B Virus Studies11.3%
  • Liver Disease and Transplantation4.1%
  • HIV/AIDS drug development and treatment3.6%
  • Hepatitis Viruses Studies and Epidemiology2.5%
  • Other45.7%

Coauthors

All papers

Open in search
  1. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

    Authors: Zobair M. Younossi, Maria Stepanova, Janus P. Ong, Ira M. Jacobson, Elisabetta Bugianesi, Ajay Duseja, Yuichiro Eguchi, Vincent Wai‐Sun Wong, Francesco Negro, Yusuf Yılmaz, Manuel Romero‐Gómez, Jacob George, Aijaz Ahmed, Robert J. Wong, Issah Younossi, Mariam Ziayee, Arian Afendy - Clinical Gastroenterology and Hepatology 2018 cited by 810

  2. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

    Authors: Patrick Marcellin, Edward Gane, Marı́a Buti, Nezam H. Afdhal, William Sievert, Ira M. Jacobson, M. Kay Washington, G. Germanidis, John F. Flaherty, Raul Aguilar Schall, Jeffrey D. Bornstein, Kathryn M. Kitrinos, G. Mani Subramanian, John G. McHutchison, E. Jenny Heathcote - The Lancet 2012 cited by 1,780

  3. Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study

    Authors: Manal F. Abdelmalek, Arun J. Sanyal, Atsushi Nakajima, Brent A. Neuschwander‐Tetri, Zachary Goodman, Eric Lawitz, Stephen A. Harrison, Ira M. Jacobson, Kento Imajo, Nadege Gunn, Dina Halegoua‐DeMarzio, Takemi Akahane, Bradly Boone, Masayuki Yamaguchi, Arkendu Chatterjee, Giridhar Tirucherai, Diane E. Shevell, Shuyan Du, Edgar D. Charles, Rohit Loomba - Clinical Gastroenterology and Hepatology 2023 cited by 99

  4. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

    Authors: Zobair M. Younossi, Maria Stepanova, Janus P. Ong, Yusuf Yılmaz, Ajay Duseja, Yuichiro Eguchi, Mohamed El‐Kassas, Marlén Castellanos, Jacob George, Ira M. Jacobson, Elisabetta Bugianesi, Vincent Wai‐Sun Wong, Marco Arrese, Victor de Lédinghen, Manuel Romero‐Gómez, Nahúm Méndez‐Sánchez, Aijaz Ahmed, Robert J. Wong, Georgios Papatheodoridis, Lawrence Serfaty, Issah Younossi, Fatema Nader, Mariam Ziayee, Arian Afendy - Clinical Gastroenterology and Hepatology 2018 cited by 167

  5. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

    Authors: Jordan J. Feld, Ira M. Jacobson, Christophe Hézode, Tarik Asselah, Peter Ruane, Norbert H. Gruener, Armand Abergel, Alessandra Mangia, Ching‐Lung Lai, Henry Lik‐Yuen Chan, Francesco Mazzotta, Christophe Moreno, Eric M. Yoshida, Stephen D. Shafran, William Towner, Tram T. Tran, John McNally, Anu Osinusi, Evguenia S. Svarovskaia, Yanni Zhu, Diana M. Brainard, John G. McHutchison, Kosh Agarwal, Stefan Zeuzem - New England Journal of Medicine 2015 cited by 1,116

  6. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

    Authors: Man‐Fung Yuen, Tarik Asselah, Ira M. Jacobson, Maurizia Rossana Brunetto, Harry L.A. Janssen, Tetsuo Takehara, Jin Hou, Thomas N. Kakuda, Tom Lambrecht, Maria Beumont, Ronald Kalmeijer, Carine Guinard‐Azadian, Cristiana Mayer, John Jezorwski, Thierry Verbinnen, Oliver Lenz, Umesh Shukla, Michael Biermer, Stefan Bourgeois, Thomas Vanwolleghem, Frederik Nevens, Yves Horsmans, Hans Van Vlierberghe, Ana Catharina de Seixas Santos Nastri, Marcus Lacerda, Alnoor Ramji, Brian Conway, Carla S. Coffin, Harry L.A. Janssen, Scott Fung, Stephen D. Shafran, Jin Hou, Jan Šperl, Petr Urbánek, Stanislav Plíšek, Václav Hejda, Didier Samuel, Karine Lacombe, Fabien Zoulim, Dominique Guyader, F. Raffi, Tarik Asselah, Marc Bourlière, Marie‐Noëlle Hilleret, Heiner Wedemeyer, Julian Schulze zur Wiesch, Kathrin Sprinzl, Kathrin Sprinzl, Gudrun Hilgard, Michael Sabranski, Keikawus Arastéh, Henry LY Chan, Man‐Fung Yuen, Vincent Wai‐Sun Wong, Maurizia Rossana Brunetto, Gloria Taliani, Pietro Andreoné, Pietro Lampertico, Masayuki Kurosaki, Hiroshi Yatsuhashi, Kei Fujiwara, Tetsuo Takehara, Tomokazu Kawaoka, Yasuhiro Asahina, Hirayuki Enomoto, Kazuhisa Yabushita, Kazuo Notsumata, Koichi Takaguchi, Naoto Kawabe, Naoya Kato, Naoto Kawabe, Tadashi Namisaki, Yoshiyuki Suzuki, Jung‐Hwan Yoon, Sang Hoon Ahn, Young‐Suk Lim, Seung Woon Paik, Kuang Kiat Kiew, Rosmawati Mohamed, Soek Siam Tan, Yeong Yeh Lee, Maria Hlebowicz, Hanna Berak, Jacek Gąsiorowski, Waldemar Halota, Ewa Janczewska, Natalia Geyvandova, Viacheslav Morozov, А. А. Андреева, Д. А. Гусев, E. I. Bessonova, М. Ф. Осипенко, Svetlana Romanova, Natalia Gankina, Olga Sagalova, Tatiana Stepanova, Olga Sagalova, M. Diago, Fernandez Inmaculada, José Luís Calleja and 24 more - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 76

  7. Diagnosis and Management of Primary Biliary Cholangitis

    Authors: Zobair M. Younossi, David Bernstein, Mitchell L. Shiffman, Paul Y. Kwo, W. Ray Kim, Kris V. Kowdley, Ira M. Jacobson - The American Journal of Gastroenterology 2018 cited by 209

  8. Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

    Authors: W. Ray Kim, Rohit Loomba, Thomas Berg, Raul E. Aguilar Schall, Leland J. Yee, Phillip Dinh, John F. Flaherty, Eduardo B. Martins, Terry M. Therneau, Ira M. Jacobson, Scott Fung, Selım Gürel, Marı́a Buti, Patrick Marcellin - Cancer 2015 cited by 214

  9. Prevalence of Chronic Hepatitis B Virus Infection in the United States

    Authors: Joseph K. Lim, Mindie H. Nguyen, W. Ray Kim, Robert G. Gish, Ponni Perumalswami, Ira M. Jacobson - The American Journal of Gastroenterology 2020 cited by 190

  10. Diagnosis and Management of Hepatitis Delta Virus Infection

    Authors: Calvin Pan, Robert G. Gish, Ira M. Jacobson, Ke‐Qin Hu, Heiner Wedemeyer, Paul Martin - Digestive Diseases and Sciences 2023 cited by 47

  11. Thrombocytopenia associated with chronic liver disease

    Authors: Nezam H. Afdhal, John G. McHutchison, Robert S. Brown, Ira M. Jacobson, Michael P. Manns, Fred Poordad, Babette B. Weksler, Rafael Esteban - Journal of Hepatology 2008 cited by 576

  12. Boceprevir for Untreated Chronic HCV Genotype 1 Infection

    Authors: Fred Poordad, Jonathan McCone, Bruce R. Bacon, Savino Bruno, Michael P. Manns, Mark Sulkowski, Ira M. Jacobson, K. Rajender Reddy, Zachary Goodman, Navdeep Boparai, Mark J. DiNubile, Vilma Sniukiene, Clifford A. Brass, Janice K. Albrecht, Jean–Pierre Bronowicki - New England Journal of Medicine 2011 cited by 2,502

  13. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Authors: Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo, Mario Chojkier, Norman Gitlin, Massimo Puoti, Manuel Romero‐Gómez, Jean-Pierre Zarski, Kosh Agarwal, Peter Buggisch, Graham R. Foster, Norbert Bräu, Marı́a Buti, Ira M. Jacobson, G. Mani Subramanian, Xiao Ding, Hongmei Mo, Jenny C. Yang, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, Alessandra Mangia, Patrick Marcellin - New England Journal of Medicine 2014 cited by 1,708

  14. Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

    Authors: Eric Lawitz, Alessandra Mangia, David Wyles, M. Rodríguez‐Torres, Tarek Hassanein, Stuart C. Gordon, Michael Schultz, Mitchell Davis, Zeid Kayali, K. Rajender Reddy, Ira M. Jacobson, Kris V. Kowdley, Lisa M. Nyberg, G. Mani Subramanian, Robert H. Hyland, Sarah Arterburn, Deyuan Jiang, John McNally, Diana M. Brainard, William T. Symonds, John G. McHutchison, Aasim Sheikh, Zobair M. Younossi, Edward Gane - New England Journal of Medicine 2013 cited by 1,782

  15. Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices

    Authors: Zobair M. Younossi, Kathleen E. Corey, Naim Alkhouri, Mazen Noureddin, Ira M. Jacobson, Brian Lam, Stephen Clement, Rita Basu, Stuart C. Gordon, Natarajan Ravendhra, Puneet Puri, Mary E. Rinella, Peter Scudera, Ashwani K. Singal, Linda Henry - Alimentary Pharmacology & Therapeutics 2020 cited by 93

  16. Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection

    Authors: Man‐Fung Yuen, Kosh Agarwal, Xiaoli Ma, Tuan Nguyen, Eugene R. Schiff, Hie‐Won Hann, Douglas T. Dieterich, Ronald Nahass, James Park, Sing Chan, Steven‐Huy B. Han, Edward Gane, Michael Bennett, Katia Alves, Marc Evanchik, Ran Yan, Qi Huang, Uri Lopatin, Richard J. Colonno, Julie Ma, Steven Knox, Luisa M. Stamm, Maurizio Bonacini, Ira M. Jacobson, Walid S. Ayoub, Frank Weilert, Natarajan Ravendhran, Alnoor Ramji, Paul Y. Kwo, Magdy Elkhashab, Tarek Hassanein, Ho Bae, Jacob Lalezari, Scott Fung, Mark Sulkowski - Journal of Hepatology 2022 cited by 35

  17. Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset

    Authors: Edgar D. Charles, Claudia Brunetti, Svetlana Marukian, Kimberly Ritola, Andrew H. Talal, Kristen Marks, Ira M. Jacobson, Charles M. Rice, Lynn B. Dustin - Blood 2011 cited by 207

  18. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

    Authors: Andrew J. Muir, Sanjeev Arora, Gregory T. Everson, Robert Flisiak, Jacob George, Reem Ghalib, Stuart C. Gordon, Todd Gray, Susan Greenbloom, Tarek Hassanein, Jan Hillson, Maria Arantxa Horga, Ira M. Jacobson, Lennox Jeffers, Kris V. Kowdley, Eric Lawitz, Stefan Lueth, M. Rodríguez‐Torres, Vinod K. Rustgi, Lynn Shemanski, Mitchell L. Shiffman, Subasree Srinivasan, Hugo E. Vargas, John M. Vierling, Dong Xu, Juan Carlos López-Talavera, Stefan Zeuzem - Journal of Hepatology 2014 cited by 147

  19. Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life

    Authors: Zobair M. Younossi, Maria Stepanova, Eric Lawitz, K. Rajender Reddy, Vincent Wai‐Sun Wong, Alessandra Mangia, Andrew J. Muir, Ira M. Jacobson, C. Stephen Djedjos, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader, Andrei Racila - The American Journal of Gastroenterology 2019 cited by 52

  20. Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection

    Authors: Mark Sulkowski, Kosh Agarwal, Xiaoli Ma, Tuan Nguyen, Eugene R. Schiff, Hie‐Won Hann, Douglas T. Dieterich, Ronald Nahass, James Park, Sing Chan, Steven‐Huy B. Han, Edward Gane, Michael Bennett, Katia Alves, Marc Evanchik, Ran Yan, Qi Huang, Uri Lopatin, Richard J. Colonno, Julie Ma, Steven Knox, Luisa M. Stamm, Maurizio Bonacini, Ira M. Jacobson, Walid S. Ayoub, Frank Weilert, Natarajan Ravendhran, Alnoor Ramji, Paul Y. Kwo, Magdy Elkhashab, Tarek Hassanein, Ho Bae, Jacob Lalezari, Scott Fung, Man‐Fung Yuen - Journal of Hepatology 2022 cited by 41

  21. Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

    Authors: Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres, K. Rajender Reddy, Tarek Hassanein, Ira M. Jacobson, Eric Lawitz, Anna S. Lok, Federico Hinestrosa, Paul J. Thuluvath, Howard Schwartz, David R. Nelson, Gregory T. Everson, Timothy Eley, Megan Wind‐Rotolo, Shu-Pang Huang, Min Gao, Dennis Hernandez, Fiona McPhee, Diane L. Sherman, R. Hindes, William T. Symonds, C Pasquinelli, Dennis M. Grasela - New England Journal of Medicine 2014 cited by 1,193

  22. Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

    Authors: Ira M. Jacobson, Stuart C. Gordon, Kris V. Kowdley, Eric M. Yoshida, M. Rodríguez‐Torres, Mark Sulkowski, Mitchell L. Shiffman, Eric Lawitz, Gregory T. Everson, Michael Bennett, Eugene R. Schiff, M. Tarek Al-Assi, G. Mani Subramanian, Di An, M. Lin, John McNally, Diana M. Brainard, William T. Symonds, John G. McHutchison, Keyur Patel, Jordan J. Feld, Stephen Pianko, David R. Nelson - New England Journal of Medicine 2013 cited by 1,082

  23. Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

    Authors: Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko, Adrian M. Di Bisceglie, K. Rajender Reddy, Natalie Bzowej, Patrick Marcellin, Andrew J. Muir, Péter Ferenci, Robert Flisiak, Jacob George, Mario Rizzetto, Daniel Shouval, Ricard Solà, Rubén Terg, Eric M. Yoshida, Nathalie Adda, Leif Bengtsson, Abdul J. Sankoh, Tara L. Kieffer, Shelley George, Robert S. Kauffman, Stefan Zeuzem - New England Journal of Medicine 2011 cited by 2,377

  24. Hepatitis C Virus RNA Functionally Sequesters miR-122

    Authors: Joseph M. Luna, Troels K. H. Scheel, Tal Danino, Katharina S. Shaw, Aldo Mele, John J. Fak, Eiko Nishiuchi, Constantin N. Takacs, Maria Teresa Catanese, Ype P. de Jong, Ira M. Jacobson, Charles M. Rice, Robert B. Darnell - Cell 2015 cited by 337